GMED: Globus Medical Inc - Class A Company Profile & Statistics

About

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.

Info & Links

CEO

Daniel T. Scavilla

Headquarters

2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

5,000

Globus Medical Inc - Class A Statistics

Valuation Measures

Market Capitalization²

11.42B

Enterprise Value

11.24B

Enterprise Value/EBITDA(ttm)

18.08

Price to Earnings Ratio(ttm)

28.42

Price to Sales(ttm)

4.53

Price to Book(mrq)

2.75

Price to Cash(ytd)

22.85

Profitability

Gross Margin(ttm)

58.15%

Operating Margin(ttm)

16.07%

Profit Margin(ttm)

3.65%

Return on Equity(ttm)

9.98%

Return on Invested Capital(ttm)

2.23%

Return on Assets(ttm)

7.92%

Income Statement

Revenue(ttm)

2.48B

Revenue Per Share(ttm)

18.20

Gross Profit(ttm)

1.44B

EBITDA(ttm)³

621.58M

Net Income Available to Common(ttm)

91.51M

Diluted EPS(ttm)

0.67

Share Statistics

Beta (5Y Monthly)

1.19

52-Week Change

76.61%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

136.17M

Dividend Yield

0.00%

Float⁴

110.92M

% Held by Insiders

18.54%

% Held by Institutions

95.16%

Balance Sheet

Total Cash(mrq)

694.71M

Total Cash Per Share(mrq)

5.10

Total Debt(mrq)

437.14M

Total Debt/Equity(mrq)

10.74%

Current Ratio(mrq)

2.51%

Quick Ratio(mrq)

1.64%

Book Value Per Share(mrq)

29.94

Cash Flow

Operating Cash Flow Per Share(ytd)

2.25

Free Cash Flow(ytd)

211.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GMED

Globus Medical Inc - Class A

Globus Medical Inc - Class A Profile